BioNTech SE Welcomes New CFO

In a significant leadership update, BioNTech SE has announced the appointment of Ramon Zapata-Gomez as its new Chief Financial Officer, starting July 1, 2025. Zapata-Gomez, currently the CFO at Novartis's global biomedical research unit, is set to bring a wealth of experience from his tenure across North America, Europe, and Latin America.

A New Chapter for BioNTech

Helmut Jeggle, Chairman of the Supervisory Board, highlighted Zapata-Gomez's "deep finance expertise" and his ability to navigate market dynamics effectively. "His leadership and understanding of global markets will be invaluable as we continue to innovate and grow," Jeggle remarked.

Expressing his enthusiasm, Zapata-Gomez shared his eagerness to contribute to BioNTech's mission of "improving patients' lives." His appointment marks a new chapter for BioNTech as it seeks to strengthen its position in the biotechnology sector.